bioRxivNeurosciencePreprint
Molecular Signatures of Normal Pressure Hydrocephalus: A Large-scale Proteomic Analysis of Cerebrospinal Fluid
Aida KamalianiD, Siavash Shirzadeh BaroughiD, Sara Grace HoiD, Marilyn AlbertiD, Mark Gregory LucianoiD, Sevil YaşariD, Abhay MoghekariD
Abstract
Given the persistent challenge of differentiating idiopathic Normal Pressure Hydrocephalus (iNPH) from similar clinical entities, we conducted an in-depth proteomic study of cerebrospinal fluid (CSF) in 28 shunt-responsive iNPH patients, 38 Mild Cognitive Impairment (MCI) due to Alzheimers disease, and 49 healthy controls. Utilizing the Olink Explore 3072 panel, we identified distinct proteomic profiles in iNPH that highlight significant downregulation of synaptic markers and cell-cell adhesion proteins. Alongside vimentin and inflammatory markers upregulation, these results suggest ependymal layer and transependymal flow dysfunction. Moreover, downregulation of multiple proteins associated with congenital hydrocephalus (e.g., L1CAM, PCDH9, ISLR2, ADAMTSL2, and B4GAT1) points to a possible shared molecular foundation between congenital hydrocephalus and iNPH. Through orthogonal partial least squares discriminant analysis (OPLS-DA), a panel comprising 13 proteins has been identified as potential diagnostic biomarkers of iNPH, pending external validation. These findings offer novel insights into the pathophysiology of iNPH, with implications for improved diagnosis.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Use of Integrative Proteomic Analysis to Uncover Shared Molecular Signatures Across Distinct Forms of Hydrocephalus
Gowthami Mahendran, Piriyankan Kirupaharan, … Bonnie L Blazer-Yost·bioRxiv·Nov 5, 2026
- Inference of Diagnostic Markers and Therapeutic Targets from CSF proteomics for the Treatment of Hydrocephalus
A. Horowitz, P. Saugier-Veber, V. Gilard·bioRxiv·May 26, 2020
- Fibrinogen and Complement Factor H are promising CSF protein biomarker(s) for Parkinson's disease with cognitive impairment- A Proteomics and ELISA based study
Aditi Naskar, Albert Stezin, … Phalguni Anand Alladi·ACS Chemical NeurosciencePeer-reviewed·Feb 24, 2022
- Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid using mass spectrometry-based proteomics
Yura Jang, Sungtaek Oh, … Alexander Y. Pantelyat·bioRxiv·Oct 5, 2023
- Proteome Profiling of Cerebrospinal Fluid Reveals Novel Biomarker Candidates for Parkinson's Disease
Özge Karayel, Sebastian Virreira Winter, … Matthias Mann·Cell Reports MedicinePeer-reviewed·Jun 1, 2022
- Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1
Khushboo Singhal, Matthew Tyler Menold, … Forbes D. Porter·Biomarker ResearchPeer-reviewed·May 9, 2026